Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
IsoEnergy (T.ISO) Announces Acquisition of Anfield Energy (V.AEC) (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GW Pharmaceuticals Plc GWPHV



NDAQ:GWPHV - Post by User

GW Pharmaceuticals Plc > Kalytera Therapeutics
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(76)
•••
Comment by Isodog2018on Dec 06, 2019 1:10am
208 Views
Post# 30427794

RE:RE:Kalytera Therapeutics

RE:RE:Kalytera Therapeutics

indaknownewfie wrote: I think this would be a perfect company to either partner with or buy out. Two patents, orphan drug status, phase II Clinical trial complete with fast track phase three recommendation from FDA 


I remember this Company at $0.08,....thanks for the update 

GWPH is definitely a winner!

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities